Abortion Pill Ruling Is a Win for Women’s Health: Lisa Jarvis

June 13, 2024, 5:15 PM UTC

The Supreme Court on Thursday preserved women’s access to a vital form of health care, maintaining full access to the medication abortion pill mifepristone.

Although women in the US still face unconscionable barriers to accessing reproductive health care — which compromise our bodily autonomy and put our lives on the line — it’s still worth celebrating the rare times when reason reigns.

Mifepristone, taken in combination with misoprostol, is considered by the Food and Drug Administration to be effective within the first 10 weeks of a pregnancy — a period when the majority of abortions are completed. The pills have become an increasingly ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.